Applied Dna Sciences (NASDAQ:BNBX) Stock Price Down 12.2% – What’s Next?

Applied Dna Sciences Inc (NASDAQ:BNBX)’s share price was down 12.2% during trading on Thursday . The stock traded as low as $0.3710 and last traded at $0.3710. Approximately 99,644 shares were traded during mid-day trading, a decline of 63% from the average daily volume of 266,547 shares. The stock had previously closed at $0.4226.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Applied Dna Sciences in a research note on Friday, April 24th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.

Applied Dna Sciences Stock Performance

The company has a market cap of $2.67 million, a price-to-earnings ratio of -0.01 and a beta of 0.52. The stock has a 50-day moving average of $0.48.

Applied Dna Sciences (NASDAQ:BNBX) last released its quarterly earnings results on Friday, May 15th. The company reported ($0.68) earnings per share (EPS) for the quarter. Applied Dna Sciences had a negative net margin of 1,647.25% and a negative return on equity of 349.95%. The company had revenue of $1.02 million during the quarter.

About Applied Dna Sciences

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.